Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Central nervous system disorders following hematopoietic stem cell transplantation: a prospective observational study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP)

Non-interventional Prospective Studies

Complications: infectious

Complications: non-infectious

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Martin Schmidt-Hieber

A prospective outcome study on patients with profound combined immune deficiency (p-CID)

Retrospective Studies

Inborn Errors Working Party (IEWP)

Type de traitement

Investigateur principal

Multi-centre retrospective study to describe the use and outcomes of ECP in combination with new treatment protocols in Acute and Chronic GvHD

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Dr. Olaf Penack

LATE COMPLICATIONS AFTER AUTOLOGOUS HSCT FOR AUTOIMMUNE DISEASES: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Autoimmune Diseases Working Party (ADWP)

Transplant Complications Working Party (TCWP)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Kirill Kirgizov

Post AHSCT (Autologous Hematopoietic Stem Cell Transplantation) management for patients with systemic sclerosis: a prospective, non-interventional approach across Europe (NISSC-2)

Non-interventional Prospective Studies

Autoimmune Diseases Working Party (ADWP)

Type de traitement

Investigateur principal

Pr Dominique Farge

Trend and outcome of HSCT in Thalassemia inside the EBMT

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Baronciani Donatella

Tendances et résultats de la greffe de cellules souches hématopoïétiques (GCSH) dans la thalassémie au sein de l’EBMT

Études rétrospectives

Autres anomalies non malignes

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Baronciani Donatella

Impact of AB0 Incompatibility on HSCT outcome in hemoglobinopathies: A Retrospective Registry Study from the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Katharina Kleinschmidt

Outcomes after graft failure of allogeneic hematopoietic stem cell transplantation in patients with SCD

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Josu de la Fuente

The impact of pre-transplant extramedullary disease on the outcome of allogeneic hematopoietic cell transplantation for Acute Myeloid Leukemia in Children- A combined CIBMTR and EBMT analysis

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Patients who undergo a Stem cell Transplant may be at risk of being admitted to the PICU

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Myeloablative conditioning for allo-HSCT in pediatric ALL and AML below 2 years

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

André Willasch